Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
about
Ammonia as a Potential Neurotoxic Factor in Alzheimer's DiseaseProtective Effects of Wogonin against Alzheimer's Disease by Inhibition of Amyloidogenic Pathway.Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer's Disease-like Neurotoxicity.Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease.Resveratrol and Brain Mitochondria: a Review.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer's Disease in Aged Women with Breast Cancer in Taiwan.Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells.Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.Extracellular Vesicle Biology in Alzheimer's Disease and Related Tauopathy.Physical exercise and glaucoma: a review on the roles of physical exercise on intraocular pressure control, ocular blood flow regulation, neuroprotection and glaucoma-related mental health.β-Ecdysterone protects SH-SY5Y cells against β-amyloid-induced apoptosis via c-Jun N-terminal kinase- and Akt-associated complementary pathways.Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease.After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning.Impact of Nitric Oxide Bioavailability on the Progressive Cerebral and Peripheral Circulatory Impairments During Aging and Alzheimer's Disease.Tanshinone I Induces Mitochondrial Protection through an Nrf2-Dependent Mechanism in Paraquat-TreatedHuman Neuroblastoma SH-SY5Y Cells.Blood Ammonia as a Possible Etiological Agent for Alzheimer's Disease.Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's DiseaseAgeing, Cellular Senescence and Neurodegenerative Disease
P2860
Q26739873-034EFCAF-8548-4E48-82CA-C1613FA34EC3Q33819805-18830309-655E-4050-9ECD-D8788879C7FEQ36531568-02B1AACD-B3E6-4AD6-A47F-69D50A9840D6Q38633186-7E7F322D-4C48-46EA-9FA6-629CD2898A36Q38883083-1D59D6C6-CDE7-4541-BB6F-4427C681F884Q39173672-9A32A8AB-5945-4776-83C6-2A8E40D61171Q39400621-772C91DD-35AB-4151-AF74-ADD1B98F8981Q41456073-31DDBF34-7851-49BB-B5BF-8C7263DC502BQ46266115-7CFBA013-3E11-4590-AC86-48EA02CE5437Q46313170-F0BBA62D-B8E9-4374-B962-EC7EB55EA165Q47353532-065DAC44-55AE-4CE8-B8A7-209B8C22B460Q47555362-98B49B39-2A00-408C-939C-8192D2A65D9AQ48251216-049B36FE-7A13-4E96-AF45-5D7EEA850A3FQ49787603-5087BD31-52DF-4F50-AFAF-97E0F996E3ACQ49904223-9330F701-5270-4321-8597-63B2B2318628Q51758674-44FCF0F5-88C9-4E60-852E-FCF31BA0BF4BQ53004544-61D43447-5427-4489-8D1C-232B72125017Q53397937-D2A6BE04-2296-4A5A-8D7D-0FE1CFFBE894Q57479995-50BAD220-B33A-4FF3-9E3B-DB789553AC8DQ59133878-D5E8B6C7-7FF0-423E-B551-9ABB54E6471B
P2860
Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
@en
type
label
Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
@en
prefLabel
Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
@en
P2093
P2860
P1476
Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
@en
P2093
Benedict C Albensi
Chris Cadonic
Mohammad Golam Sabbir
P2860
P2888
P304
P356
10.1007/S12035-015-9515-5
P577
2015-11-04T00:00:00Z
P5875
P6179
1005871575